The South Korea Botulinum Toxin Type A
Market size is anticipated to reach USD 386.9
million by 2030 and expanding at a CAGR of 10.4% from 2024 to 2030,
according to a new report by Grand View Research, Inc. The rising aesthetic
consciousness among the South Korean population fuels the demand for the
market. South Koreans place a high value on physical appearance, with a strong
cultural emphasis on beauty and youthfulness. This societal trend has led to an
increasing demand for non-invasive cosmetic procedures, including botulinum
toxin treatments, to enhance and maintain one's appearance. For instance, the
popularity of K-beauty standards and the influence of media and celebrities
have heightened awareness and acceptance of aesthetic treatments. This growing
focus on aesthetics is not limited to any specific age group, as both younger
and older demographics are seeking treatments to address their cosmetic
concerns, further driving the market for botulinum toxin products.
The growing consumer preference for health, safety,
and authenticity has driven a strong focus on natural and organic products.
According to the International Trade Administration article published in
September 2023, despite a slight decrease in total local production and exports
in 2022, South Korea remains one of the top 10 beauty markets globally. This
trend presents new opportunities in the botulinum toxin type A market as
consumers increasingly seek safe and natural cosmetic solutions. Additionally,
the Ministry of Food & Drug Safety (MFDS) has introduced guidelines for
natural and organic cosmetics, supporting the development and growth of this
niche market within the botulinum toxin sector.
List of Key Players in the South Korea Botulinum Toxin
Type A Market
- Hugel
- Medytox
- Daewoong
- Galderma
- Ipsen
- Huons Global
- Pharma Research BIO
- AbbVie
Request a free sample copy or view report summary: South Korea Botulinum Toxin Type A
Market Report
South Korea Botulinum Toxin Type A Market Report
Highlights
- In terms of application, the upper face segment held the largest
share of 51.85% in 2023 and is anticipated to grow at fastest growth rate
over the forecast period owing to increasing demand for aesthetic
treatments aimed at reducing wrinkles in areas such as the forehead,
glabella, and crow's feet.
- Based on gender, the female segment held the largest share of 82.02%
as women in South Korea often experience early signs of aging and skin
dullness, influenced by hormonal fluctuations such as declining estrogen
levels.
- Based on age, 31 to 59 Years segment held the largest share of over
44.35% in 2023. This age group is typically more concerned with signs of
aging such as wrinkles and fine lines, making botulinum toxin type A
injections a popular choice for rejuvenating facial appearance.
- Based on end use, the specialty clinics & aesthetic centers
segment held the largest share of over 42.99% in 2023. These facilities
provide a range of cosmetic procedures under one roof, catering to diverse
patient needs. Moreover, clinics employ skilled dermatologists and
aesthetic practitioners who specialize in facial rejuvenation and cosmetic
enhancements.
South Korea Botulinum Toxin Type
A Market Report Scope
|
Report Attribute |
Details |
|
Market
size value in 2024 |
USD 214.0
million |
|
Revenue
forecast in 2030 |
USD 386.9
million |
|
Growth
rate |
CAGR of
10.4% from 2024 to 2030 |
|
Historical
data |
2018 -
2023 |
|
Forecast period |
2024 - 2030 |
Related Press Release@ South Korea Botulinum Toxin Type A Industry
Analysis
South Korea Botulinum Toxin Type A Market Segmentation
Grand View Research has segmented the South Korea
Botulinum Toxin Type A market based on application, gender, age, and
end-use.
South Korea Botulinum Toxin Type A Application Category
Outlook (Revenue, USD Million; 2018 - 2030)
- Upper Face
- Glabellar Wrinkles
- Forehead Wrinkles
- Crow’s Feet
- Mid Face
- Lower Face
- Body
South Korea Botulinum Toxin Type A Gender Outlook
(Revenue, USD Million; 2018 - 2030)
- Female
- Male
South Korea Botulinum Toxin Type A Age Outlook (Revenue,
USD Million; 2018 - 2030)
- Below 30 Years
- 31 to 59 Years
- Over 60 Years
South Korea Botulinum Toxin Type A End-use Outlook
(Revenue, USD Million; 2018 - 2030)
- Hospitals
- Specialty Clinics & Aesthetic Centers
- Medspas
Explore Horizon, the world's most expansive market
research database
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment